08.30 – REGISTRATION OPENS (COFFEE)

09.00 - 9.30 SCNP GENERAL ASSEMBLY (MEMBERS ONLY)

9:30 – 9.45 SCNP PRESIDENTS’ WELCOME TO SCNP 61^ST ANNUAL MEETING

• Sophie Erhardt, Professor, Karolinska Institutet, Sweden

9.45 – 10.30 SCNP 2020 OPENING LECTURE

Moderator: Carl Björkholm, PhD, Jansen Pharmaceuticals, Sweden

Speaker: Future therapies for Alzheimer’s disease

• Lars Lannfelt, Professor, Uppsala University, Sweden

10.30 COFFEE BREAK AND POSTER VIEWING

10.50 – 12.30 GENETICS AND IMMUNOLOGICAL ASPECTS IN PSYCHIATRY  

Moderator: Sophie Erhardt (Stockholm, Sweden)

Diagnosis and treatment of maladaptive immunological responses presenting with psychiatric phenotypes

• Janet Cunningham, Assoc. Prof., Uppsala University, Sweden

Treatment of minocycline and schizophrenia

• Carl Sellgren. MD, PhD, Karolinska Institutet, Sweden

Shared genetic risk across psychiatric and neurological disorders”.

• Olav Bjerkehagen Smeland, MD, PhD, University of Oslo, Norway)

Understanding the genetics of psychiatric disorders in the era of GWAS

• Sarah Bergen, PhD, Karolinska Institutet, Sweden

Lithium - pharmacokinetics, genetics and nanofluidics

• Martin Schalling, Professor, Karolinska Institutet, Sweden

12.30 – 13.30 LUNCH AND POSTER VIEWING

13.30 – 15.00 SCNP YOUNG SCIENTIST SYMPOSIUM

Moderator: Gregers Wegener, Professor, Aarhus University, Denmark

• Speakers selected based on competition

15:00 – 15:30 COFFEE BREAK AND POSTER VIEWING

15.30 – 17.00 Treatment of depressive disorders (20 min + 10min)

Moderator: Ingrid Dieset, MD, PhD, Oslo University, Norway

Management of treatment-resistant depression: old ideas (& new)

• Elias Eriksson, Professor, Gothenburg University, Sweden

Real-world effectiveness of pharmacotherapies in psychotic depression

• Heidi Taipale, PhD, Karolinska Institutet, Sweden

Honorary member lecture

Psychedelics in depression – opportunities and challenges

• Prof. Ole Andreassen, Professor Oslo University, Norway

17.00 – POSTER VIEWING (REFRESHMENTS)

19.00 – DINNER (See the Social Programme)

08.30 - 9.15 KEYNOTE LECTURE

Moderator: Bo Söderpalm, Professor, Gothenburg University, Sweden

Cannabis — The Good, The Bad and the Ugly in Relation to Psychiatric Disorders

• Yasmin Hurd, Professor, Icahn School of Medicine at Mount Sinai, USA

9.15 – 10.15 In Memorian of Torgny H. Svensson

Moderator: Sophie Erhardt, Professor, Karolinska Institutet, Sweden)

Professor Torgny H. Svensson 1945-2020

• Göran Engberg, Professor, Karolinska Institutet, Sweden

The Torgny H. Svensson Award Lecture

• TBA

10.15 – 10.45 COFFEE BREAK AND POSTER VIEWING

10.45 – 12.15 UPDATE ON NEW DRUGS

Moderator: Henry Karlsson, Assoc. Prof., University of Turku, Finland

Targeting Brain Kynurenic Acid for Cognitive Improvement

• Robert Schwarcz, Professor, University of Maryland School of Medicine, USA

Ulotaront: A Novel TAAR1 Agonist in Development for the Treatment of Schizophrenia

• Nicholas DeMartinis, MD, VP Head of Global Clinical Research Psychiatry, Sunovion Pharmaceuticals Inc.

Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder

• Susanne Bejerot, Professor, Örebro University, Sweden

12.15 - 13:15 LUNCH AND POSTER VIEWING

13.15 – 14.00 KEYNOTE LECTURE

Moderator: Bo Söderpalm, Professor, Gothenburg University, Sweden

Treatment Strategies for ADHD and Co-occurring Substance Use/Use Disorders

• Frances Levin, Professor, Columbia University, USA

14.00 -14.20 COFFEE BREAK AND POSTER VIEWING

14.20 – 16.00 Addiction, Suicide and ADHD

Moderator: Carl Björkholm, PhD, Jansen Pharmaceuticals, Sweden

Suicide prevention- how to turn the tide?

• Merete Nordentoft, Professor, University of Copenhagen, Denmark

Neuromodulation of subjective experience

• Siri Leknes, Professor, University of Oslo, Norway)

Role of Cognition in Alcohol Use Disorders

• Nitya Jayaram Lindström, PhD, Karolinska Institutet, Sweden

Gut-brain axis and addictive disorders

• Elisabet Jerlhag Holm, Professor, Gothenburg University, Sweden

Prevalence and pattern of intravenous use of methylphenidate in Iceland

• Gudrun Bjarnadottir, PhD, Landspitali University Hospital, Iceland

16:00 CONCLUSION OF MEETING

Sophie Erhardt & Bo Söderpalm